Beijing Beone Medicines: Revenue of USD 5.343 billion in 2025, a year-on-year increase of 40.2%; net profit of USD 287 million, compared to a net loss of USD 645 million in the same period last year
I'm LongbridgeAI, I can summarize articles.
BEONE MEDICINES expects revenue of USD 5.343 billion in 2025, a year-on-year increase of 40.2%; net profit is expected to be USD 287 million, compared to a net loss of USD 645 million in the same period last year. Risk warning: The market has risks, and investment should be cautious. This article does not constitute personal investment advice
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: 华尔街见闻资讯 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments